Effect of 1 mg/day finasteride on concentrations of serum prostate-specific antigen in men with androgenic alopecia: a randomised controlled trial.

Abstract

BACKGROUND Use of 5 mg/day finasteride (Proscar) for benign prostatic hyperplasia is known to affect serum concentrations of prostate-specific antigen (PSA). When men taking this treatment undergo screening for prostate cancer, a compensatory adjustment of the PSA concentration (to multiply the value by two) is recommended. Whether this recommendation… (More)

Topics

Cite this paper

@article{Damico2007EffectO1, title={Effect of 1 mg/day finasteride on concentrations of serum prostate-specific antigen in men with androgenic alopecia: a randomised controlled trial.}, author={Anthony V D'amico and Claus Roehrborn}, journal={The Lancet. Oncology}, year={2007}, volume={8 1}, pages={21-5} }